腦動極光-B(06681.HK)公佈年度業績 年度收入大幅增長82.01%
格隆匯3月28日丨腦動極光-B(06681.HK)發佈公告,截至2024年12月31日止年度,公司收入增加至人民幣122.31百萬元,同比增長了82.01%。公司的研發開支增加至人民幣119.42百萬元,增加了31.62%。公司錄得截至2024年12月31日止年度的虧損爲人民幣198.61百萬元,而上年度的虧損爲人民幣359.12百萬元。
公司的毛利增加至截至2024年12月31日止年度的人民幣54.01百萬元,增加了68.47%。公司的毛利增加主要是由於系統的銷量大幅增加以及使用系統的醫院和患者數量增加。
截至本公告日期,公司的核心產品已納入中國30個省份的省級醫保報銷目錄。公司致力於協助全國的醫療機構建立認知障礙診療中心,與醫療機構建立長期的業務合作關係,促進中國認知障礙數字療法市場的發展。截至本公告日期,公司已幫助中國超過150家醫院建立認知中心,包括多家獲得國家衛健委所設置的各個醫學專科「國家醫學中心」認證的領先醫院。公司致力於將腦科學研究成果轉化爲數字療法產品,造福認知障礙患者。
公司已建立廣泛的數字療法產品管線。截至本公告日期,核心產品已就四種主要類型認知障礙的八種適應症實現商業化,並正就其他幾種認知障礙適應症進行開發。截至本公告日期,公司有另外三款產品在中國獲監管批準、另外一款產品在歐盟獲監管批準及六款候選產品處於臨牀前和臨牀開發或註冊過程的不同階段。公司於公司獲得監管批準的司法管轄區就公司的產品及候選產品享有權利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.